COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,187 Articles (22,713 medRxiv, 8,474 bioRxiv)

Most recent first Previous |  Page 2246: Articles 22451-22460  | Next

COVID-19 Mortality in Cancer Patients: A Report from a Tertiary Cancer Centre in India
Mehta, A., Vasudevan, S., Parkash, A., Sharma, A., Vashist, T., Krishna, V.
10.1101/2020.09.14.20194092 — Posted: 2020-09-15
Phylogenomic reveals multiple introductions and early spread of SARS-CoV-2 into Peru
Juscamayta Lopez, E., Tarazona, D., Valdivia Guerrero, F., Rojas Serrano, N., Carhuaricra, D., Maturrano Hernandez, L., Gavilan Chavez, R.
10.1101/2020.09.14.296814 — Posted: 2020-09-14
Self-assembling nanoparticles presenting receptor binding domain and stabilized spike as next-generation COVID-19 vaccines
He, L., Lin, X., Wang, Y., Abraham, C., Sou, C., Ngo, T., Zhang, Y., Wilson, I. A., Zhu, J.
10.1101/2020.09.14.296715 — Posted: 2020-09-14
Non-permissive SARS-CoV-2 infection of neural cells in the developing human brain and neurospheres
Pedrosa, C. d. S. G., Goto-Silva, L., Gomes, I. C., Souza, L. R. Q., Vitória, G., Ornelas, I. M., Karmirian, K., Mendes, M. A., Salerno, J. A., Puig-Pijuan, T., Veríssimo, C., Temerozo, J. R., Furtado, D. R., Borges, H. L., Souza, T. M. L., Guimarães, M. Z. P., Rehen, S.
10.1101/2020.09.11.293951 — Posted: 2020-09-14
Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein's Receptor Binding Domain and Recombinant Human ACE2.
Olaleye, O. A., Kaur, M., Onyenaka, C. C.
10.1101/2020.09.13.295691 — Posted: 2020-09-14
Single-cell RNA Expression of SARS-CoV-2 Cell Entry Factors in Human Endometrium during Preconception
Vilella Mitjana, F., Wang, W., Moreno Gimeno, I., Quake, S., Simon, C.
10.1101/2020.09.14.296806 — Posted: 2020-09-14
The Coronavirus Network Explorer: Mining a large-scale knowledge graph for effects of SARS-CoV-2 on host cell function
Krämer, A., Billaud, J.-N., Tugendreich, S., Shiffman, D., Jones, M., Green, J.
10.1101/2020.09.14.296327 — Posted: 2020-09-14
SARS CoV-2 nucleocapsid protein forms condensates with viral genomic RNA
Jack, A., Ferro, L. S., Trnka, M. J., Wehri, E., Nadgir, A., Costa, K., Schaletzky, J., Yildiz, A.
10.1101/2020.09.14.295824 — Posted: 2020-09-14 Discussion: Offsite
Genes with 5' terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 NSP1 protein
Rao, S., Hoskins, I., Garcia, D., Tonn, T., Ozadam, H., Sarinay Cenik, E., Cenik, C.
10.1101/2020.09.13.295493 — Posted: 2020-09-14 Discussion: Onsite | Offsite
A dual antigen ELISA allows the assessment of SARS-CoV-2 antibody seroprevalence in a low transmission setting
Hicks, S., Pohl, K., Neeman, T., McNamara, H., Parsons, K., He, J.-S., Ali, S., Nazir, S., Rowntree, L., Nguyen, T., Kedzierska, K., Doolan, D., Vinuesa, C., Cook, M., Coatsworth, N., Myles, P., Kurth, F., Sander, L., Gruen, R., Mann, G., George, A., Gardiner, E., Cockburn, I.
10.1101/2020.09.09.20191031 — Posted: 2020-09-14 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).